Vantive Limited 
Address :
Wavertree Technology Park, 2 Wavertree Boulevard,
Liverpool,
L7 9PE,
United Kingdom
Liverpool,
L7 9PE,
United Kingdom
Telephone :
+44 (0)800 0234 002
Email :
Website :
Description :
Chronic kidney disease (CKD) is an urgent and growing global challenge. We estimate there are as many as 4 million end-stage renal disease (ESRD) patients globally, and millions more people go undiagnosed; this is a situation projected to grow annually. While your patient population is growing, your time and cost resources are not increasing. We understand you need meaningful innovations and services that help you deliver better outcomes for more patients.
In the UK, there are an estimated 68,249 patients receiving Renal Replacement Therapy (RRT). Transplantation is the most common treatment modality (57%), haemodialysis (HD) is used in 35.4% and peritoneal dialysis (PD) in 5.6% of RRT patients. Of the HD population, 2% receive home haemodialysis (HHD).)1
For more than 60 years, we have partnered with the nephrology community to focus on pioneering care in both haemodialysis (HD) and peritoneal dialysis (PD). We maintain that pioneering spirit today through new therapies like expanded haemodialysis (HDx) and remote patient management with Sharesource.
Renal home therapies
An increase in home therapies is widely regarded to be positive for both patients and healthcare professionals. Evidence exists that increasing levels of patient engagement can be clinically and economically effective2. Where patients are encouraged to take an active role as a key player in protecting their health, coping with acute episodes of ill health and managing their chronic disease, patients’ experience and satisfaction improves.
Vantive has two residential training facilities which support patients to self-care that help teach NHS patients to successfully manage their home dialysis.
CRRT Therapy
Intensive care unit (ICU) patients under your care have the highest need for monitoring and treatment in the hospital, and they often have comorbidities. We know caring for your ICU patients is often a race against the clock.
We’re committed to being your partner with industry-leading technologies and services that support your ability to deliver multi-organ support in the ICU.
Acute kidney injury (AKI) is an increasingly common complication of acute illnesses in ICUs and hospitals and may require continuous renal replacement therapy (CRRT). As a leader in CRRT for more than 20 years, our technology can help the treatment of patients suffering from AKI. We are committed to a partnership approach to advance patient therapy options and provide comprehensive training with ongoing clinical and technical support.
In the UK, there are an estimated 68,249 patients receiving Renal Replacement Therapy (RRT). Transplantation is the most common treatment modality (57%), haemodialysis (HD) is used in 35.4% and peritoneal dialysis (PD) in 5.6% of RRT patients. Of the HD population, 2% receive home haemodialysis (HHD).)1
For more than 60 years, we have partnered with the nephrology community to focus on pioneering care in both haemodialysis (HD) and peritoneal dialysis (PD). We maintain that pioneering spirit today through new therapies like expanded haemodialysis (HDx) and remote patient management with Sharesource.
Renal home therapies
An increase in home therapies is widely regarded to be positive for both patients and healthcare professionals. Evidence exists that increasing levels of patient engagement can be clinically and economically effective2. Where patients are encouraged to take an active role as a key player in protecting their health, coping with acute episodes of ill health and managing their chronic disease, patients’ experience and satisfaction improves.
Vantive has two residential training facilities which support patients to self-care that help teach NHS patients to successfully manage their home dialysis.
CRRT Therapy
Intensive care unit (ICU) patients under your care have the highest need for monitoring and treatment in the hospital, and they often have comorbidities. We know caring for your ICU patients is often a race against the clock.
We’re committed to being your partner with industry-leading technologies and services that support your ability to deliver multi-organ support in the ICU.
Acute kidney injury (AKI) is an increasingly common complication of acute illnesses in ICUs and hospitals and may require continuous renal replacement therapy (CRRT). As a leader in CRRT for more than 20 years, our technology can help the treatment of patients suffering from AKI. We are committed to a partnership approach to advance patient therapy options and provide comprehensive training with ongoing clinical and technical support.